David Ege

Chief Tech/Sci/R&D Officer at ADC THERAPEUTICS SA

52 year

Health Technology

Consumer Services

Commercial Services

Profile

David S.
Ege currently works at ADC Therapeutics SA, as Chief Technical Officer from 2024.
Dr. Ege also formerly worked at Merck & Co., Inc., as Executive Director-Vaccines & Biologics from 2015 to 2019, Penn Biotech Group Healthcare Consulting, as President, and Seres Therapeutics, Inc., as Chief Technology Officer & Executive VP from 2020 to 2024.
Dr. Ege received his doctorate degree from the University of Pennsylvania and undergraduate degree from Princeton University.

David Ege active positions

Companies	Position	Start
ADC THERAPEUTICS SA	Chief Tech/Sci/R&D Officer	01/10/2024

All active positions of David Ege

Former positions of David Ege

Companies	Position	End
SERES THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	31/10/2024
MERCK & CO., INC.	Corporate Officer/Principal	01/06/2019
Penn Biotech Group Healthcare Consulting Penn Biotech Group Healthcare Consulting Miscellaneous Commercial ServicesCommercial Services Operates as a student organization which provides project services on health and biotechnology sector	President	-

See the detail of David Ege's experience

Training of David Ege

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Ege's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Merck & Co., Inc. Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines	Health Technology
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Princeton University Princeton University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
ADC Therapeutics SA ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers	Health Technology
Seres Therapeutics, Inc. Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome	Health Technology
Penn Biotech Group Healthcare Consulting Penn Biotech Group Healthcare Consulting Miscellaneous Commercial ServicesCommercial Services Operates as a student organization which provides project services on health and biotechnology sector	Commercial Services

See company connections